Skip to main content
Watch Insiders
IRDHealthcare

Opus Genetics Inc (IRD) Insider Trading

In the last 90 days, 6 Opus Genetics Inc (IRD) insiders reported no open-market purchases and 7 sales totaling $5,857,568. Source: SEC Form 4 filings.

SEC-reported filing activity is provided for research purposes and is not investment advice.

90-day C-suite buyers
0
90-day purchase value
$0.00
Corporate buyers
0
Latest transaction
Oct 23, 2026

Executive filings

Open-market transaction history

Purchase and sale summaries are ordered by the latest reported transaction date.

Open-market insider purchase and sale transactions
DateInsider nameRoleTypeSharesPriceTotal value
Oct 23, 2026Joseph K SchachleChief Operating OfficerSale4,767$3.57$16,994
Oct 23, 2026Benjamin R YerxaPresidentSale33,189$3.54$117,366
Oct 23, 2026Robert E. GagnonChief Financial OfficerSale14,000$3.55$49,650
Oct 23, 2026George MagrathChief Executive OfficerSale9,591$3.59$34,384
Sep 30, 2026Foundation Fighting Blindness Retinal Degeneration FundCorporate insiderSale556,000$4.96$2,755,981
Sep 30, 2026Foundation Fighting Blindness Inc.Corporate insiderSale556,000$4.96$2,755,981
Sep 3, 2026Robert E. GagnonChief Financial OfficerSale28,000$4.54$127,212
Jul 23, 2026Benjamin R YerxaPresidentSale7,429$2.97$22,064
Jul 23, 2026Joseph K SchachleChief Operating OfficerSale4,644$2.94$13,653
Jul 23, 2026George MagrathChief Executive OfficerSale9,475$2.95$27,926
🔒 Create Free Insider Alerts — Join Watch Insiders

Common questions

IRD insider trading FAQ

Are IRD insiders buying or selling?
Over the last 90 days, IRD insiders were net sellers, reporting $0.00 of open-market purchases and $5,857,568 of sales.
When was the last IRD insider purchase?
No open-market insider purchase of Opus Genetics Inc stock was reported in the last 90 days.
Where does IRD insider trading data come from?
Watch Insiders reads the SEC Form 4 filings that Opus Genetics Inc officers, directors, and 10% owners submit to EDGAR, and refreshes this page daily.